<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03382743</url>
  </required_header>
  <id_info>
    <org_study_id>171217</org_study_id>
    <nct_id>NCT03382743</nct_id>
  </id_info>
  <brief_title>Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy</brief_title>
  <official_title>Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy - a Randomized Control Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      lidocaine spray is used endocervical before office hysteroscopy to reduce the pain
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      5 sprays of Lidocaine is applied 3 minutes before office hysteroscopy
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2017</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain sensation</measure>
    <time_frame>The VAS will be applied immediately after the procedure ended</time_frame>
    <description>The level of pelvic pain will be rated according to a 10-point visual analogue scale (VAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Procedure time</measure>
    <time_frame>immediately after the process</time_frame>
    <description>from introduction of the office hysteroscopy through the external cervical os and the visualization of the uterine cavity</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pain Uterus</condition>
  <arm_group>
    <arm_group_label>Group A (Lidocaine group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 sprays of endocervical Lidocaine 10% spray ( AstraZeneca, bedforshire) are used 3 minutes before office hysteroscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B (control group)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>office hysteroscopy is done without analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Endocervical Lidocaine spray</intervention_name>
    <description>5 sprays of endocervical Lidocaine spray (10%) is used 3 minutes before office hysteroscopy</description>
    <arm_group_label>Group A (Lidocaine group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients indicated for diagnostic hysteroscopy for infertility or AUB. Postmenstrual
        between days 7 and 11 of the cycle ( except in irregular bleeding)

        Exclusion Criteria:

        Contraindication to office hysteroscopy Neurological disorders affecting the evaluation of
        pain. Previous cervical surgery.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kasr El Ainiy Hospital</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sarah M Hassan, Lecturer</last_name>
      <phone>01003733671</phone>
      <email>saramohamed7880@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kasr Alaini hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah M hassan, lecturer</last_name>
      <phone>01003733671</phone>
      <email>saramohamed7880@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Wafaa R Desouky, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amira M Yehia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2017</study_first_submitted>
  <study_first_submitted_qc>December 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 26, 2017</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>sarah mohamed hassan</investigator_full_name>
    <investigator_title>principal investigator ,lecturer of obstetrics and gynecology</investigator_title>
  </responsible_party>
  <keyword>office hysteroscopy</keyword>
  <keyword>Lidocaine spray</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

